2026 Marc Feldmann: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	155	103	97	10	10	789	100618
Medicine	155	951	873	99	93	801	100768

Research.com Recognitions

2026 - Research.com Immunology in United Kingdom Leader Award
2026 - Research.com Medicine in United Kingdom Leader Award
2025 - Research.com Immunology in United Kingdom Leader Award
2025 - Research.com Medicine in United Kingdom Leader Award
2023 - Research.com Medicine in United Kingdom Leader Award
2022 - Research.com Immunology in United Kingdom Leader Award
2020 - Distinguished Fellows of the American Association of Immunologists (AAI)
2014 - Canada Gairdner International Award
2010 - Member of the National Academy of Sciences
2008 - Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson for their role in the discovery of tumor necrosis factor-alpha, or TNF-alpha, as an effective therapeutic target for rheumatoid arthritis and other autoimmune diseases.
2006 - Fellow of the Royal Society, United Kingdom
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)
Member of the Association of American Physicians
Member of the European Molecular Biology Organization (EMBO)

Overview

Marc Feldmann is affiliated with the University of Oxford in the United Kingdom and primarily works in the field of Medicine. Their research spans several subfields including Infectious Diseases, Neurology, Immunology, Rheumatology, and Surgery.

The scientist has contributed to topics related to COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, SARS-CoV-2 and COVID-19 Research, Dupuytren's Contracture and Treatments, Inflammasome and immune disorders, as well as Cannabis and Cannabinoid Research. Their work addresses significant medical challenges with focused studies in inflammation and immune responses.

Significant recent publications by Marc Feldmann include:

"An inflammatory cytokine signature predicts COVID-19 severity and survival", 2020, Nature Medicine
"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed", 2020, The Lancet
"Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19", 2020, Science Immunology
"COVID-19 therapeutics: Challenges and directions for the future", 2022, Proceedings of the National Academy of Sciences
"Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment", 2020, The Lancet Rheumatology

Frequent co-authors who have collaborated with Feldmann include Jagdeep Nanchahal, Lynn Williams, T. B. Layton, Fiona E. McCann, and Tracy Hussell.

Major venues where their research has been published encompass:

Proceedings of the National Academy of Sciences
bioRxiv (Cold Spring Harbor Laboratory)
Nature Communications
The Lancet Rheumatology
NIHR Open Research

Over the course of their career, Feldmann has received multiple recognitions and awards such as Distinguished Fellow of the American Association of Immunologists (AAI) in 2020, the Canada Gairdner International Award in 2014, membership in the National Academy of Sciences since 2010, the Dr. Paul Janssen Award for Biomedical Research from Johnson & Johnson in 2008 for work identifying tumor necrosis factor-alpha as a therapeutic target in autoimmune diseases, Fellowship of the Royal Society in the United Kingdom since 2006, membership in the Association of American Physicians, and membership in the European Molecular Biology Organization (EMBO).

Best Publications

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

P E Lipsky;D M van der Heijde;E W St Clair;D E Furst

4728
Citations
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

R Maini;E W St Clair;F Breedveld;D Furst

3822
Citations
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

Marc Feldmann;Fionula M. Brennan;Ravinder N. Maini

3432
Citations
An inflammatory cytokine signature predicts COVID-19 severity and survival.

Diane Marie Del Valle;Seunghee Kim-Schulze;Hsin-Hui Huang;Noam D. Beckmann

2602
Citations
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

M J Elliott;R N Maini;M Feldmann;J R Kalden

2211
Citations
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

Ravinder N. Maini;Ferdinand C. Breedveld;Joachim R. Kalden;Josef S. Smolen

2195
Citations
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

Marc Feldmann;Ravinder N. Maini

1744
Citations
IRF5 Promotes Inflammatory Macrophage Polarization and TH1-TH17 Responses

Thomas Krausgruber;Katrina Blazek;Timothy Smallie;Saba Alzabin

1668
Citations
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY

G F Bottazzo;R Pujol-Borrell;T Hanafusa;M Feldmann

1538
Citations
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha

M J Elliott;R N Maini;M Feldmann;A Long-Fox

1483
Citations
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

Richard O. Williams;Marc Feldmann;Ravinder N. Maini

1316
Citations
Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

F M Brennan;D Chantry;A Jackson;R Maini

1305
Citations
Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

T Hirano;T Matsuda;M Turner;N Miyasaka

1006
Citations
Rheumatoid Arthritis

Unknown

971
Citations
Role of interleukin-1beta in postoperative cognitive dysfunction.

Mario Cibelli;Antonio Rei Fidalgo;Niccolò Terrando;Niccolò Terrando;Daqing Ma

929
Citations
Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

M J Elliott;R N Maini;M Feldmann;A Long-Fox

891
Citations
Development of anti-TNF therapy for rheumatoid arthritis

Marc Feldmann

890
Citations
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

A. M. Malfait;R. Gallily;P. F. Sumariwalla;A. S. Malik

822
Citations
Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Marc Feldmann;Ravinder N Maini

816
Citations
Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline.

Niccolò Terrando;Claudia Monaco;Daqing Ma;Brian M. J. Foxwell

801
Citations
Assessment of antibodies to double‐stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open‐label and randomized placebo‐controlled trials

P. J. Charles;R. J. T. Smeenk;J. De Jong;M. Feldmann

763
Citations
IRF5 PROMOTES INFLAMMATORY MACROPHAGE POLARIZATION AND TH1/TH17 RESPONSE

T Krausgruber;K Blazek;T Smallie;H Lockstone

0
Citations

Frequent Co-Authors

Fionula M. Brennan University of Oxford

Ravinder N. Maini Imperial College London

Brian M. J. Foxwell Imperial College London

Richard O. Williams University of Oxford

Ewa M. Paleolog University of Oxford

Marco Londei University College London

Peter Erb University of Basel

Martin R. Turner University of Oxford

Peter C. Taylor University of Oxford

Evangelos Andreakos Academy of Athens

External Links

Wikipedia of Marc Feldmann Personal website of Marc Feldmann

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open diverse career opportunities in healthcare and research. Nurse practitioner programs, especially online, offer flexible pathways to advance clinical expertise. If you're considering a nursing path, programs highlighted as easy nurse practitioner programs to get into can help kickstart your clinical career with practical, accessible options.

For specialization in mental health, psychiatric nurse practitioner degrees are a strong complement to Immunology knowledge. Top-ranked options with excellent clinical site support can be found among the top pmhnp programs, ensuring hands-on experience vital for patient care. For students mindful of budget, there are also cheapest pmhnp programs that balance cost-effectiveness with quality education.

Understanding the financial outlook is crucial when choosing a path. The dnp salary by state information provides valuable insights into the earning potential across different regions. This data helps guide decisions on where to study and work post-graduation, aligning your Immunology background with rewarding career possibilities.